Exelon Corp

EXC remains in a Stage 2 advancing regime with a clear higher-high/higher-low sequence following its corrective reset. Recent pullback into rising short-term EMAs and the 50 DMA offers a structurally sound entry zone amid continued demand dominance. Short-term indicators (RSI mid-range, OB/OS neutral) show no exhaustion, supporting a tactical long entry. Key risk remains a potential shift into Stage 3 distribution if support fails, but current dynamics favor participation on the pullback.

• ↑2026 operating EPS of $2.81–$2.91 reaffirmed by management
• ↑Plans $41.3B capex over 2025–28, with 70% toward transmission
• ↓Pennsylvania’s withdrawn rate cases threaten investment recovery